Editas Medicine,Inc. (NASDAQ:EDIT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors …Market ExclusiveCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein … Continue reading
RT Boosts Immunotherapy in NSCLCMedPage TodayPatients with advanced non-small cell lung cancer (NSCLC) lived significantly longer without disease progression if they received radiation therapy prior to starting immunotherapy, a retrospective review sho… Continue reading
|
Chinese Begin Stem Cell Trial for Parkinson’s (Scientific American)
MedPage Today In the next several months, surgeons in the Chinese city of Zhengzhou will initiate a clinical trial using human embryonic stem cells to treat Parkinson’s disease, first coaxing the cells to develop into neuron precursors and then injecting them … |